http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2701525-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f62c742b87bf1c93c55fed3f7db7ef4c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 |
| filingDate | 2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bc8da78ce7160dd9719ef280b5768d |
| publicationDate | 2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2701525-C1 |
| titleOfInvention | Method of combined therapy of cervical dysplasia associated with human papilloma viruses |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely oncogynecology, and can be used for treating cervical dysplasia associated with human papilloma viruses. That is ensured by local treatment of the patient using a medicinal agent containing diindolylmethane, and before the local treatment, the patient is once injected with a human papilloma virus vaccine.EFFECT: method provides higher clinical effectiveness in cervical dysplasia ensured by systemic immunotherapy and local drug exposure.1 cl, 1 tbl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188012-A1 |
| priorityDate | 2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.